摘要 |
The invention relates to the use of compounds which exhibit an affinity for the μ-opioid receptor of at least 100 nM (Ki value, human) and an affinity for the ORL-1 receptor, wherein the ratio between the affinities ORL1/μ defined as 1/[Ki(ORL1)/Ki(μ)] is from 0.1 to 30, for the treatment of pain. |